Covered recipient · General Payments record
KUANGI HUANG
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,582.94
- Reported across 28 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $777.65 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $130.22 | 3 |
| Neurelis, Inc. | $125.00 | 1 |
| SK Life Science, Inc. | $124.10 | 1 |
| Lexicon Pharmaceuticals, Inc. | $120.60 | 1 |
| OptiNose US, Inc. | $96.96 | 1 |
| Biogen, Inc. | $83.26 | 1 |
| SANOFI-AVENTIS U.S. LLC | $81.88 | 1 |
| Ultragenyx Pharmaceutical Inc. | $15.63 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Biogen, Inc. | $83.26 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104806007 | CMS |
| GlaxoSmithKline, LLC. | $19.83 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116278944 | CMS |
| GlaxoSmithKline, LLC. | $93.01 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116438531 | CMS |
| GlaxoSmithKline, LLC. | $17.38 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116317192 | CMS |
| Lexicon Pharmaceuticals, Inc. | $120.60 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1081702545 | CMS |
| Neurelis, Inc. | $125.00 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145665236 | CMS |
| Optinose US, Inc. | $96.96 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142189226 | CMS |
| SANOFI-AVENTIS U.S. LLC | $81.88 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139859946 | CMS |
| SK Life Science, Inc. | $124.10 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154125526 | CMS |
| Ultragenyx Pharmaceutical Inc. | $15.63 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153289379 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.